Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 15, 2003

View Archived Issues

Advectus acquires option for nanopharmaceutical for Alzheimer's disease

Cell Therapeutics Scandinavia and Tanabe enter stem cell collaboration

Probactrix controls antibiotic-associated diarrhea in clinical study

Novel 5-HT6 receptor ligands claimed by GSK researchers

Pierre Fabre presents new alpha2-adrenoceptor modulators with potential in AD therapy

BMS scientists prepare and test new anti-HIV agents

Novel p38 inhibitors, their preparation and use covered by GSK patent

Roche identifies new DPP-IV inhibitors

AstraZeneca claims JNK inhibitors for use in AD and other disorders

Humira approved in E.U. for rheumatoid arthritis

Raptiva recommended for approval by advisory committee

Maxalt launched this month in Japan for migraine Rx

Potent antagonist of human glucagon receptor presented at ACS meeting

Selective ERbeta agonist endowed with potent oral antiinflammatory activity

OncoGenex and Isis expand antisense drug development partnership

AVE-5997, a selective, orally active dopamine D3 antagonist, characterized at ACS meeting

Regeneron to advance phase III Axokine program in obesity

Benicar HCT now available in U.S.

Javlor enters two new phase III trials in NSCLC and bladder cancer

BMS designs series of potent and selective Itk inhibitors as potential immunosuppressants

Enrollment completed in phase I breast cancer trial for HER-2 AutoVac Protein vaccine

Merck presents synthesis, SAR for a series of imidazole acetic acid TAFI inhibitors

FDA accepts for filing diquafosol NDA for dry eye

Phase III results for Genasense plus chemotherapy in malignant melanoma

Genzyme expands access to Myozyme

SBIR grant supports smallpox therapeutic development efforts at Aphios

New fluoroquinolone active against multidrug-resistant Gram-positive pathogens

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...